Skip to content

ALDX

Aldeyra Therapeutics, Inc.

NASDAQ · Healthcare · Biotechnology · US

$1.48
+0.00%
Ask drillr
0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
-9.5%
Price return (3m)
Form 4 filings
DateInsiderActivitySharesPrice
Jun 11, 2026Walker Neal · directorA-Award70,000$1.72
Jun 11, 2026Clark William D · directorA-Award2,323$1.72
Jun 11, 2026Clark William D · directorA-Award70,000$1.72
Jun 11, 2026Phillips Gary M. · directorA-Award4,977$1.72
Jun 11, 2026Phillips Gary M. · directorA-Award6,636$1.72
Jun 11, 2026Phillips Gary M. · directorA-Award70,000$1.72
Jun 11, 2026DOUGLAS RICHARD · directorA-Award2,323$1.72
Jun 11, 2026DOUGLAS RICHARD · directorA-Award19,909$1.72
Jun 11, 2026DOUGLAS RICHARD · directorA-Award70,000$1.72
Jun 11, 2026Miller-Rich Nancy · directorA-Award3,318$1.72
Jun 11, 2026Miller-Rich Nancy · directorA-Award70,000$1.72
Jun 11, 2026DEPTULA-HICKS DARLENE M · directorA-Award9,756$1.72
Jun 11, 2026DEPTULA-HICKS DARLENE M · directorA-Award84,557$1.72
Jun 11, 2026Bronstein Ben · directorA-Award4,977$1.72
Jun 11, 2026Bronstein Ben · directorA-Award5,309$1.72
Jun 11, 2026Bronstein Ben · directorA-Award70,000$1.72
Jun 11, 2026Walker Neal · directorA-Award3,318$1.72
Jun 5, 2026Brady Todd C · director, officer: President and CEOPurchase250,000$1.67
Mar 31, 2026Brady Todd C · director, officer: President and CEOA-Award632,318$0.00
Mar 31, 2026Brady Todd C · director, officer: President and CEOA-Award1,880,510$1.77
Mar 20, 2026DOUGLAS RICHARD · directorPurchase70,000$1.40
Mar 19, 2026Alfieri Michael · officer: Principal Financial OfficerPurchase5,000$1.42
Aug 15, 2025Alfieri Michael · officer: Principal Financial OfficerPurchase2,500$5.30
Aug 13, 2025Machatha Stephen · officer: Chief Development OfficerSale22,073$5.15
Jun 12, 2025DOUGLAS RICHARD · directorA-Award1,689$2.69
Jun 12, 2025Miller-Rich Nancy · directorA-Award62,728$2.69
Jun 12, 2025Miller-Rich Nancy · directorA-Award2,413$2.69
Jun 12, 2025Bronstein Ben · directorA-Award62,728$2.69
Jun 12, 2025Bronstein Ben · directorA-Award3,860$2.69
Jun 12, 2025Bronstein Ben · directorA-Award3,619$2.69
Institutional positioning

13F filings over the trailing two quarters

New 22Increased 52Reduced 38Sold out 125
FilerActionSharesFiled
KNOLL CAPITAL MANAGEMENT, LLCUnchanged5,475,516May 15, 2026
BLACKROCK, INC.Reduced3,763,887May 13, 2026
AQR CAPITAL MANAGEMENT LLCIncreased2,829,875May 15, 2026
VANGUARD CAPITAL MANAGEMENT LLCNew Position2,363,742May 15, 2026
KINGDON CAPITAL MANAGEMENT, L.L.C.Increased2,152,315May 15, 2026
683 CAPITAL MANAGEMENT, LLCReduced1,500,000May 15, 2026
D. E. SHAW & CO., INC.Reduced1,403,990May 15, 2026
GEODE CAPITAL MANAGEMENT, LLCIncreased1,251,652May 15, 2026
ARDSLEY ADVISORY PARTNERS LPReduced1,250,000May 15, 2026
JANE STREET GROUP, LLCIncreased1,140,991May 12, 2026
STATE STREET CORPIncreased1,124,710May 15, 2026
MILLENNIUM MANAGEMENT LLCIncreased995,243May 15, 2026
RENAISSANCE TECHNOLOGIES LLCIncreased863,187May 14, 2026
ACADIAN ASSET MANAGEMENT LLCReduced858,288May 13, 2026
VANGUARD PORTFOLIO MANAGEMENT LLCNew Position807,778May 8, 2026

Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Jun 11, 2026